PositiveNaija Public Alert 42: NAFDAC Notifies on Prohibition of Use and Sale of Bledine Infant Cereals by Chadian Authorities

PositiveNaija Public Alert 42: The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public of a report received regarding the prohibition of the use, distribution and sale of Bledine Infant Cereals, manufactured by Danone Group, a French multinational food and beverage company, by the Chadian authorities.

The report states that the ban was imposed due to non-compliance with European standards for Aflatoxin B1 (AFB1) content, a known carcinogen. Further assessments indicate that the affected Blendine products are currently circulating in Nigeria, particularly in border communities with Chad, raising significant public health concerns.

Risk Statement

The use of the banned product presents significant health risks, exposing infants and young children to the potent carcinogen Aflatoxin B1. Aflatoxin B1 is recognized as an immunotoxin agent that leads to various immune system disorders.

Product details

The affected Bledine products include:

Product Manufacturer Product Name Expiry Date
Danone Group, a French multinational food and beverage company 1.      Bledine Cereals Saveur biscuit

2.     Bledine Saveur Biscuit & Lait

3.     Bledine Miel & Lait

4.     Bledine Banane & Lait.

Expiration dates ranging from September 2026 to March 2027

All NAFDAC zonal directors and state coordinators have been instructed to conduct surveillance and remove any affected products within their respective zones and states.

Distributors, retailers, healthcare professionals, and caregivers are advised to exercise caution and ensure vigilance throughout the supply chain to prevent the distribution, sale, and use of the implicated product. It is essential to obtain all medical products from authorized and licensed suppliers. Additionally, the authenticity and physical condition of the products should be carefully verified.

Healthcare providers and consumers are encouraged to report adverse events or side effects related to the use of the implicated product to the nearest NAFDAC office, or through the use of the E-reporting platforms available on the NAFDAC website www.nafdac.gov.ng or via the Med-safety application available for download on android and IOS stores or via e-mail on pharmacovigilance@nafdac.gov.ng

 

PositiveNaija Public Alert

The PositiveNaija Public Alert 42 initiative is aimed at keeping Nigerians well-informed particularly in regards to their safety and development. For future developments on this news, kindly follow up through the official communication channels of the reporting/regulatory authority.

We publish these alerts for free and will appreciate your support for our work – Moniepoint – 9064503292 – Toju Micheal Ogbe

Subscribe
Notify of
guest

0 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments